Search

Your search keyword '"Eckard Hamelmann"' showing total 200 results

Search Constraints

Start Over You searched for: Author "Eckard Hamelmann" Remove constraint Author: "Eckard Hamelmann" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
200 results on '"Eckard Hamelmann"'

Search Results

1. Perceptions of the impact of individual allergic rhinitis symptoms: A survey of ARIA clinical experts

2. Efficacy and safety of gene therapy with onasemnogene abeparvovec in children with spinal muscular atrophy in the D-A-CH-region: a population-based observational studyResearch in context

3. Chronic stridor in a toddler after ingestion of a discharged button battery: a case report

4. Ingestion of several rubber gloves: A case report on Pica syndrome

5. Initiation, response assessment, and switch of antibody therapies in patients with severe asthma – A survey among German specialists

6. Diversities of allergic pathologies and their modifiers: Report from the second DGAKI-JSA meeting

7. Definitions of non-response and response to biological therapy for severe asthma: a systematic review

8. A comparison of tiotropium, long-acting β2-agonists and leukotriene receptor antagonists on lung function and exacerbations in paediatric patients with asthma

9. Allergen immunotherapy during the COVID‐19 pandemic—A survey of the German Society for Allergy and Clinical Immunology

10. Expert meeting report: towards a joint European roadmap to address the unmet needs and priorities of paediatric asthma patients on biologic therapy

11. Decision-Making in the Pediatric Emergency Department—A Survey of Guidance Strategies among Residents

12. Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic overview of systematic reviews

14. Local T/B cooperation in inflamed tissues is supported by T follicular helper-like cells

15. Erratum to: Allergen immunotherapy for allergic rhinoconjunctivitis: protocol for a systematic review

16. Erratum to: Allergen immunotherapy for allergic asthma: protocol for a systematic review

17. EUFOREUM Berlin 2023: Optimizing care for type 2 inflammatory diseases from clinic to AI: A pediatric focus.

18. Limited Reimbursement and Underuse of Digital Healthcare Concepts Are Major Barriers to Clinical Allergological Care in Germany

19. S3 Guideline Urticaria. Part 2: Treatment of urticaria – German‐language adaptation of the international S3 guideline

20. S3‐Leitlinie Urtikaria. Teil 2: Therapie der Urtikaria – deutschsprachige Adaption der internationalen S3‐Leitlinie

21. S3‐Leitlinie Urtikaria. Teil 1: Klassifikation und Diagnostik der Urtikaria – deutschsprachige Adaptation der internationalen S3‐Leitlinie

23. Development of Core Outcome Measures sets for paediatric and adult Severe Asthma (COMSA)

24. Care with allergen immunotherapy for allergic respiratory diseases in Germany—Predictors and deficits

25. Assessment of the long-term safety and efficacy of dupilumab in children with asthma: LIBERTY ASTHMA EXCURSION

26. Epidemiologie, Krankheitslast und gesundheitsökonomische Aspekte

28. White Paper Erdnussallergie - Teil 1: Epidemiologie, Burden of Disease, gesundheitsökonomische Aspekte

29. S3 Guideline Urticaria. Part 1: Classification and diagnosis of urticaria - German-language adaptation of the international S3 Guideline

30. Allergisches Asthma bronchiale

31. Update Leitlinie zum Management IgE-vermittelter Nahrungsmittelallergien – S2k-Leitline der DGAKI

32. Praktischer Umgang mit allergischen Reaktionen auf COVID-19-Impfstoffe

33. Precision medicine reaching out to the patients in allergology – a German-Japanese workshop report

34. S2k-Leitlinie zur Diagnostik und Therapie von Patienten mit Asthma – Addendum 2020

35. Schwere allergische Reaktionen nach COVID-19-Impfung mit dem Impfstoff von Pfizer/BioNTech in Großbritannien und USA

36. VerSITA - eine Studie zur Versorgungssituation der Allergen-Immuntherapie bei allergischen Atemwegserkrankungen

37. COVID-19-Impfungen von Patienten mit Allergien und Typ2-entzündlichen Erkrankungen bei gleichzeitiger Antikörpertherapie (Biologika) : Ein Positionspapier der Deutschen Gesellschaft für Allergologie und Klinische Immunologie (DGAKI) und dem Ärzteverband Deutscher Allergologen (AeDA)

38. Update of the S2k guideline on the management of IgE-mediated food allergies

39. Chitinase-Induced Airway Hyperreactivity and Inflammation in a Mouse Model of Nonallergic Asthma

40. Health care situation in patients with allergic respiratory diseases with special focus on specific immunotherapy

41. Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management

42. Anwendung von Biologika bei allergischen und Typ-2-entzündlichen Erkrankungen in der aktuellen Covid-19-Pandemiea, b, c

43. Forced Expiratory Flow (FEF25–75%) as a Clinical Endpoint in Children and Adolescents with Symptomatic Asthma Receiving Tiotropium: A Post Hoc Analysis

44. Development of the Microbiota and Associations With Birth Mode, Diet, and Atopic Disorders in a Longitudinal Analysis of Stool Samples, Collected From Infancy Through Early Childhood

45. Comparative Responses in Lung Function Measurements with Tiotropium in Adolescents and Adults, and Across Asthma Severities: A Post Hoc Analysis

46. Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines ‐ recommendations on the use of biologicals in severe asthma

47. ARIA-Leitlinie 2019: Behandlung der allergischen Rhinitis im deutschen Gesundheitssystem

48. Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic

49. Allergen immunotherapy in the current COVID-19 pandemic: A position paper of AeDA, ARIA, EAACI, DGAKI and GPA

50. Early priming of asthma and respiratory allergies: Future aspects of prevention: A statement by the European Forum for Education and Research in Allergy and Airway Disease (EUFOREA) and the EAACI-Clemens von Pirquet Foundation

Catalog

Books, media, physical & digital resources